314 related articles for article (PubMed ID: 21356133)
1. Optimal H1N1 vaccination strategies based on self-interest versus group interest.
Shim E; Meyers LA; Galvani AP
BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S4. PubMed ID: 21356133
[TBL] [Abstract][Full Text] [Related]
2. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
[TBL] [Abstract][Full Text] [Related]
3. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.
Borse RH; Shrestha SS; Fiore AE; Atkins CY; Singleton JA; Furlow C; Meltzer MI
Emerg Infect Dis; 2013 Mar; 19(3):439-48. PubMed ID: 23622679
[TBL] [Abstract][Full Text] [Related]
4. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
;
MMWR Recomm Rep; 2009 Aug; 58(RR-10):1-8. PubMed ID: 19713882
[TBL] [Abstract][Full Text] [Related]
5. Optimizing vaccine allocation at different points in time during an epidemic.
Matrajt L; Longini IM
PLoS One; 2010 Nov; 5(11):e13767. PubMed ID: 21085686
[TBL] [Abstract][Full Text] [Related]
6. Optimal pandemic influenza vaccine allocation strategies for the Canadian population.
Tuite AR; Fisman DN; Kwong JC; Greer AL
PLoS One; 2010 May; 5(5):e10520. PubMed ID: 20463898
[TBL] [Abstract][Full Text] [Related]
7. Planning for the next influenza H1N1 season: a modelling study.
Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
[TBL] [Abstract][Full Text] [Related]
8. Modeling optimal age-specific vaccination strategies against pandemic influenza.
Lee S; Golinski M; Chowell G
Bull Math Biol; 2012 Apr; 74(4):958-80. PubMed ID: 22147102
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
Yang P; Zhang L; Shi W; Lu G; Cui S; Peng X; Zhang D; Liu Y; Liang H; Pang X; Wang Q
Influenza Other Respir Viruses; 2012 Nov; 6(6):381-8. PubMed ID: 22212858
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
Emborg HD; Krause TG; Hviid A; Simonsen J; Mølbak K
BMJ; 2011 Jan; 344():d7901. PubMed ID: 22277542
[TBL] [Abstract][Full Text] [Related]
11. Prioritization of delayed vaccination for pandemic influenza.
Shim E
Math Biosci Eng; 2011 Jan; 8(1):95-112. PubMed ID: 21361402
[TBL] [Abstract][Full Text] [Related]
12. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.
Vajo Z; Tamas F; Sinka L; Jankovics I
Lancet; 2010 Jan; 375(9708):49-55. PubMed ID: 20018367
[TBL] [Abstract][Full Text] [Related]
14. Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.
Hoschler K; Maharjan S; Whitaker H; Southern J; Okai B; Baldevarona J; Turner PJ; Andrews NJ; Miller E; Zambon M
Vaccine; 2020 Mar; 38(12):2660-2670. PubMed ID: 32070679
[TBL] [Abstract][Full Text] [Related]
15. Inspecting the Mechanism: A Longitudinal Analysis of Socioeconomic Status Differences in Perceived Influenza Risks, Vaccination Intentions, and Vaccination Behaviors during the 2009-2010 Influenza Pandemic.
Maurer J
Med Decis Making; 2016 Oct; 36(7):887-99. PubMed ID: 26416814
[TBL] [Abstract][Full Text] [Related]
16. Modelling mitigation strategies for pandemic (H1N1) 2009.
Gojovic MZ; Sander B; Fisman D; Krahn MD; Bauch CT
CMAJ; 2009 Nov; 181(10):673-80. PubMed ID: 19825923
[TBL] [Abstract][Full Text] [Related]
17. Pandemic H1N1 influenza: predicting the course of a pandemic and assessing the efficacy of the planned vaccination programme in the United States.
Towers S; Feng Z
Euro Surveill; 2009 Oct; 14(41):19358. PubMed ID: 19883540
[TBL] [Abstract][Full Text] [Related]
18. A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.
Dubé E; Fannie D; Vladimir G; Julie BA; Chantal S; France L; François BD; Shelly M; Ian G; Nicole B
BMC Public Health; 2011 Feb; 11():128. PubMed ID: 21342511
[TBL] [Abstract][Full Text] [Related]
19. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
20. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
